Systems and methods for multi-analysis
Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
1. An automated method of performing three or more assays for detecting a plurality of analytes in a biological sample, comprising:
receiving a cartridge comprising a biological sample obtained from a subject in a single biological sample processing device, wherein the cartridge further comprises:
at least three assay vessels for performing the three or more assays to detect a plurality of analytes in the biological sample,
wherein (i) each of the at least three assay vessels performs a different one of the three or more assays, (ii) the three or more assays comprise a nucleic acid amplification and immunoassay, and (iii) the plurality of analytes comprise an antibody, antigen, and nucleic acid; and
reagents for performing the three or more assays,
at least a first inert liquid for use in the nucleic acid amplification and a second inert liquid for use in the immunoassay, wherein the first and second inert liquids are immiscible with and have lower densities than the sample, and wherein the first and second inert liquids are different;
and wherein the biological sample processing device comprises:
at least one automated sample handling device comprising a first pipette head and a second pipette head, wherein the first pipette head and the second pipette head are mounted on a common support structure and are independently movable and independently controllable in relation to the other:
a thermal control unit providing thermocycling for the nucleic acid amplification;
and at least one optical detector;
performing in the biological sample processing device the three or more assays by introducing the sample, at least one of the reagents, and at least the first inert liquid or the second inert liquid into the assay vessel to form a barrier layer therein, wherein the three or more assays are performed at least partially in parallel, and;
detecting the presence or absence of the plurality of analytes with the at least one optical detector in the biological sample processing device;
bringing an open end of a pipette tip on the sample handling device into contact with the barrier layer in the assay vessel to cover a portion of the pipette tip, sealing the pipette tip with a portion of the barrier layer remaining on the pipette tip after the pipette tip is removed from the assay vessel.
2. The method of claim 1 , wherein the biological sample is a blood sample.
3. The method of claim 2 , wherein the blood sample obtained from the subject is about 500 μl or less.
4. The method of claim 2 , wherein the three or more assays are performed from a single blood sample obtained from the subject.
5. The method of claim 2 , wherein the blood sample is a plasma sample.
6. The method of claim 1 , wherein the cartridge comprises at least four assay vessels and the biological sample processing device performs four or more assays at least partially in parallel, wherein the four or more assays comprise a nucleic acid amplification, immunoassay, and cytometric assay, and wherein the plurality of analytes comprise an antibody, antigen, nucleic acid, and cell.
7. The method of claim 6 , wherein the biological sample processing device further comprises a cytometer.
8. The method of claim 1 , wherein the biological sample processing device further comprises a centrifuge.
9. The method of claim 1 , wherein at least one of reagents comprises beads for capturing the antibody and/or antigen from the biological sample.
10. The method of claim 1 , wherein the nucleic acid is a nucleic acid of a virus selected from measles, mumps, rubella, poliomyelitis, hepatitis A, hepatitis B, hepatitis C, hepatitis delta, hepatitis E, influenza, adenovirus, rabies, yellow fever, Epstein-Barr virus, papillomavirus, Ebola virus, Japanese encephalitis, dengue virus, hantavirus, Sendai virus, respiratory syncytial virus, orthomyxovirus, vesicular stomatitis virus, visna virus, cytomegalovirus, human immunodeficiency virus, and herpes simplex virus.
11. The method of claim 1 , wherein the at least one automated sample handling device comprises at least two different mechanisms for dispensing and/or aspirating a fluid.
12. The method of claim 11 , wherein the two different mechanisms for dispensing and/or aspirating a fluid is selected from the group positive displacement, air displacement, and suction.
13. The method of claim 1 , wherein the first pipette head is a positive displacement pipette head and the second pipette head is an air displacement pipette head.
14. The method of claim 1 , wherein the first pipette head and the second pipette head each have a coefficient of variation of about 2% or lower.
15. The method of claim 1 , wherein the at least one automated sample handling device has a dimension of about 500 cm 3 or less total volume.
16. A biological sample processing system comprising;
a cartridge, wherein the cartridge comprises:
at least three assay vessels for performing at least partially in parallel three or more assays to detect a plurality of analytes in a biological sample obtained from a subject,
wherein (i) each of the at least three assay vessels performs a different one of the three or more assays, (ii) the three or more assays comprise a nucleic acid amplification and immunoassay, and (iii) the plurality of analytes comprise an antibody, antigen, and nucleic acid; and
reagents for performing the three or more assays,
at least a first inert liquid for use in the nucleic acid amplification and a second inert liquid for use in the immunoassay, wherein the first and second inert liquids are immiscible with and have lower densities than the sample, and wherein the first and second inert liquids are different;
and a biological sample processing device comprising:
at least one automated sample handling device comprising a first pipette head and a second pipette head, wherein the first pipette head and the second pipette head are mounted on a common support structure and are independently movable and independently controllable in relation to the other;
a thermal control unit providing thermocycling for the nucleic acid amplification;
and at least one optical detector for detecting the presence or absence of the plurality of analytes;
wherein the sample handling device comprises a controller programmed to introduce the sample, at least one of the reagents, and at least the first inert liquid or the second inert liquid into the assay vessel to form a barrier layer therein and to bring a pipette tip into contact with the barrier layer on the assay vessel to cover a portion of the pipette tip, sealing the pipette tip with a portion of the barrier layer remaining on the pipette tip after the pipette tip is removed from the assay vessel.
17. The system of claim 16 , comprising at least four assay vessels for performing at least partially in parallel four or more assays, wherein the four or more assays comprise a nucleic acid amplification, immunoassay, and cytometric assay, and wherein the plurality of analytes comprise an antibody, antigen, nucleic acid, and cell.
18. The system of claim 17 , wherein the biological sample processing device further comprises a cytometer.
19. The system of claim 16 , wherein the biological sample processing device further comprises a centrifuge.
20. The system of claim 16 , wherein the at least three assay vessels are each fluidically isolated and movable.
21. The system of claim 16 , wherein the biological sample is a blood sample and the system is configured to receive a blood sample of about 500 μl or less.
22. The system of claim 16 , wherein at least one of the reagents comprises beads for capturing the antibody and/or antigen from the biological sample.
23. The system of claim 16 , wherein the nucleic acid is a nucleic acid of a virus selected from measles, mumps, rubella, poliomyelitis, hepatitis A, hepatitis B, hepatitis C, hepatitis delta, hepatitis E, influenza, adenovirus, rabies, yellow fever, Epstein-Barr virus, papillomavirus, Ebola virus, Japanese encephalitis, dengue virus, hantavirus, Sendai virus, respiratory syncytial virus, orthomyxovirus, vesicular stomatitis virus, visna virus, cytomegalovirus, human immunodeficiency virus, and herpes simplex virus.
24. The system of claim 16 , wherein the at least one automated sample handling device comprises at least two different mechanisms for dispensing and/or aspirating a fluid.
25. The system of claim 24 , wherein the two different mechanisms for dispensing and/or aspirating a fluid is selected from the group positive displacement, air displacement, and suction.
26. The system of claim 16 , wherein the first pipette head is a positive displacement pipette head and the second pipette head is an air displacement pipette head.
27. The system of claim 16 , wherein the first pipette head and the second pipette head each have a coefficent of variation of about 2% or lower.
28. The system of claim 16 , wherein the at least one automated sample handling device has a dimension of about 500 cm 3 or less total volume.